Johns Hopkins researchers find that standard PTSD treatment does not cause drug use relapse. Read More »

Several pharmaceutical companies are staying vigilant in their commitment to finding proper treatments and vaccine research and development (R&D) related to COVID-19, according to PhRMA. Read More »

Going to the emergency room can be stressful and scary for patients especially if they are over the age of 50. Read More »

Conference Call to be held Thursday, July 23, 2020 at 4:30pm ET Read More »

New Site Features More Information, Improved User Experience Read More »

Six months into the COVID-19 pandemic, pharmaceutical companies join forces to develop drugs and vaccines to eliminate the virus. Read More »

Thousands of Americans suffer from Chronic Obstructive Pulmonary Disease (COPD), but new recommendations from a pair of health organizations may help ease their discomfort. Read More »

The conference will take place virtually in conjunction with the eighth NASP Annual Meeting & Expo Virtual Experience Read More »

One of the fastest-growing pharmaceuticals companies in the country, headquartered in Lexington County, today announced several major expansion and investment projects. Read More »

Hospital pharmacists are becoming more involved in patient care and are embracing new technology, a new study found. Read More »

A study facilitated by Vizient, Inc. and recently published in the Journal of American Medical Association Internal Medicine yielded new insights about patients with presumed penicillin allergies. Read More »

PANTHERx® Rare Pharmacy announces that it has been selected by Ultragenyx Pharmaceutical as a limited distribution partner for new drug DOJOLVI™ (triheptanoin). DOJOLVI™ (a highly purified, pharmaceutical-grade, synthetic seven carbon fatty acid triglyceride) is a specially designed synthetic triglyceride compound, which was developed to treat patients with long-chain fatty acid oxidation disorders (LC-FAOD). Read More »

The National Association of Board of Pharmacy (NABP) is urging members of Congress to support federal programs to deal with the COVID-19 outbreak as well as an epidemic of opioid drug abuse in the country the virus might be fueling. Read More »

Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced that Vu Truong, Ph.D., Chief Executive Officer, will participate in Cantor Fitzgerald's Virtual Symposium: "Winning Ways to Treat Infections and COVID-19" being held on Tuesday, June 30, 2020. Read More »

The American Medical Association, American Pharmacists Association, and American Society of Health-System Pharmacists appreciates the Food and Drug Administration's (FDA's) continuing efforts to review and advise the nation on the safe and effective use of hydroxychloroquine, chloroquine, and other medications to prevent and treat coronavirus. Read More »

Telehealth can be a new frontier for pharmacists, according to the incoming president of American Pharmacists Association, the association reported on its website. Read More »

An increasing number of groups are voicing their opposition to proposals by the Trump administration to force drug companies and medical device manufacturers to source materials in the United States, according to one trade organization. Read More »

Mylan achieves key milestone to provide U.S. multiple sclerosis patients with more affordable generic version of Biogen's Tecfidera® capsules Read More »

Kaiser Permanente to join as a governing member with the goal of helping to secure supplies of essential generic medications during COVID-19 and beyond Read More »

A bill introduced by U.S. Sen. Joni Ernst (R-IA) would give companies incentives if they brought their pharmaceutical, supply and medical device manufacturers back to the United States from China, the Ripon Advance reported. Read More »